Structural and numerical variation of FLT3/ITD in pediatric AML

被引:83
作者
Meshinchi, Soheil [1 ,2 ,3 ]
Stirewalt, Derek L. [1 ,4 ]
Alonzo, Todd A. [3 ,5 ]
Boggon, Titus J. [6 ]
Gerbing, Robert B. [3 ]
Rocnik, Jennifer L. [7 ,8 ]
Lange, Beverly J. [3 ,6 ]
Gilliland, D. Gary [7 ,8 ]
Radich, Jerald P. [1 ,4 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USA
[2] Univ Washington, Med Ctr, Dept Pediat, Seattle, WA 98195 USA
[3] Childrens Oncol Grp, Arcadia, CA USA
[4] Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA
[5] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
[6] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA
[7] Brigham & Womens Hosp, Dept Pathol, Div Hematol Oncol, Boston, MA 02115 USA
[8] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
D O I
10.1182/blood-2008-01-117770
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FLT3 internal tandem duplication (FLT3/ITD) is a common somatic mutation in acute myeloid leukemia (AML) with significant variation in the position, length, and number of duplications of the FLT3 gene. We evaluated these physical characteristics in FLT3/ITD-positive patients who were treated on CCG-2941/2961 and correlated them with clinical outcome. Fifty-nine of 77 FLT3/ITD-positive patients (77%) had a single ITD, 16 (21%) had 2 ITDs, and 2 (3%) had 3 ITDs. The length of the duplicated region varied from 6 to 51 amino acids, and in all cases amino acid residues Y591-Y597 were duplicated. Structural analysis demonstrated that Y591-Y597 encodes the switch and zipper regions of the juxtamembrane domain of FLT3. In addition, 24 of 77 patients (31%) had duplication of the critical STAT5 docking sites Y589/591. Patients with longer ITDs had a worse relapse-free survival (119% vs 51%, P = .035), while the presence of more than 1 ITD was not clinically significant. Physical characteristics including the length of FLT3/ITD may influence FLT3 activation state by altering its structure and may impact response to therapy.
引用
收藏
页码:4930 / 4933
页数:4
相关论文
共 20 条
[1]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[2]   CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics:: Prognostic relevance and analysis of cooperating mutations [J].
Fröhling, S ;
Schlenk, RE ;
Stolze, I ;
Bihlmayr, J ;
Benner, A ;
Kreitmeier, S ;
Tobis, K ;
Döhner, H ;
Döhner, K .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) :624-633
[3]   The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia [J].
Gale, Rosemary E. ;
Green, Claire ;
Allen, Christopher ;
Mead, Adam J. ;
Burnett, Alan K. ;
Hils, Robert K. ;
Linch, David C. .
BLOOD, 2008, 111 (05) :2776-2784
[4]   The structural basis for autoinhibition of FLT3 by the juxtamembrane domain [J].
Griffith, J ;
Black, J ;
Faerman, C ;
Swenson, L ;
Wynn, M ;
Lu, F ;
Lippke, J ;
Saxena, K .
MOLECULAR CELL, 2004, 13 (02) :169-178
[5]   IMPROVED METHODS FOR BUILDING PROTEIN MODELS IN ELECTRON-DENSITY MAPS AND THE LOCATION OF ERRORS IN THESE MODELS [J].
JONES, TA ;
ZOU, JY ;
COWAN, SW ;
KJELDGAARD, M .
ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 :110-119
[6]  
Kiyoi H, 1999, BLOOD, V93, P3074
[7]   The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials [J].
Kottaridis, PD ;
Gale, RE ;
Frew, ME ;
Harrison, G ;
Langabeer, SE ;
Belton, AA ;
Walker, H ;
Wheatley, K ;
Bowen, DT ;
Burnett, AK ;
Goldstone, AH ;
Linch, DC .
BLOOD, 2001, 98 (06) :1752-1759
[8]   Mortality in overweight and children with acute myeloid underweight leukemia [J].
Lange, BJ ;
Gerbing, RB ;
Feusner, J ;
Skolnik, J ;
Sacks, N ;
Smith, FO ;
Alonzo, TA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (02) :203-211
[9]   Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia [J].
Meshinchi, S ;
Stirewalt, DL ;
Alonzo, TA ;
Zhang, QG ;
Sweetser, DA ;
Woods, WG ;
Bernstein, ID ;
Arceci, RJ ;
Radich, JP .
BLOOD, 2003, 102 (04) :1474-1479
[10]   Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia [J].
Meshinchi, S ;
Woods, WG ;
Stirewalt, DL ;
Sweetser, DA ;
Buckley, JD ;
Tjoa, TK ;
Bernstein, ID ;
Radich, JP .
BLOOD, 2001, 97 (01) :89-94